Oishi Chizuko, Sakuta Manabu
Department of Internal Medicine I, School of Medicine, Kyorin University.
Nihon Rinsho. 2003 Aug;61(8):1361-6.
The cause of multiple sclerosis(MS) is still obscure. However, recent therapy is making a dramatic progress. The steroid is traditional therapy, especially the common use of methylprednisolone in management of attacks of MS is based on high-dose intravenous methylprednisolone. This section are described steroid therapy of history(ACTH therapy, High-dose intravenous methylprednisolone therapy, ACTH therapy vs high-dose intravenous methylprednisolone therapy, and long term effects of steroid therapy), high-dose oral and intravenous methylprednisolone therapy, oral therapy after steroid pulse therapy and long term effects of steroid.
多发性硬化症(MS)的病因仍不明确。然而,近年来的治疗取得了显著进展。类固醇是传统疗法,尤其是在多发性硬化症发作的治疗中常用的甲基强的松龙是基于大剂量静脉注射甲基强的松龙。本节描述了类固醇治疗的历史(促肾上腺皮质激素治疗、大剂量静脉注射甲基强的松龙治疗、促肾上腺皮质激素治疗与大剂量静脉注射甲基强的松龙治疗对比以及类固醇治疗的长期影响)、大剂量口服和静脉注射甲基强的松龙治疗、类固醇脉冲治疗后的口服治疗以及类固醇的长期影响。